UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 426

Sortiert nach

Trends in Worldwide Research in Hypertension Over the Period 1999–2018: A Bibliometric Study

Hypertension (Dallas, Tex. 1979), 2020-11, Vol.76 (5), p.1649-1655

2020

Volltextzugriff (PDF)

Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension

Hypertension (Dallas, Tex. 1979), 2020-04, Vol.75 (4), p.956-965

2020

Volltextzugriff (PDF)

Work environment mediates a large part of social inequalities in the incidence of several common cardiovascular risk factors: Findings from the Gazel cohort

Social science & medicine, 2018-11, Vol.216, p.59-66

2018

Volltextzugriff (PDF)

Eplerenone Survival Benefits in Heart Failure Patients Post-Myocardial Infarction Are Independent From its Diuretic and Potassium-Sparing Effects: Insights From an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) Substudy

Journal of the American College of Cardiology, 2011-11, Vol.58 (19), p.1958-1966

2011

Volltextzugriff (PDF)

Phylogenetic analysis of West Nile virus in Quebec, Canada, 2004–2016: Co-circulation of distinct variants harbouring conserved amino acid motifs in North America

Virology (New York, N.Y.), 2019-11, Vol.537, p.65-73

2019

Volltextzugriff (PDF)

Masked hypertension: a systematic review

Journal of hypertension, 2008-09, Vol.26 (9), p.1715-1725

2008

Volltextzugriff (PDF)

The urgent need for organisational changes of hypertension management in France

La Presse médicale (1983), 2018-10, Vol.47 (10), p.839-841

2018

Volltextzugriff (PDF)

The BIAL/Biotrial case of death of a human volunteer in the first-in-human study of BIA 10-2474: Are we missing the fundamentals?

La Presse médicale (1983), 2016-09, Vol.45 (9), p.719-722

2016

Volltextzugriff (PDF)

A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism

Journal of hypertension, 2011-05, Vol.29 (5), p.980-990

2011

Volltextzugriff (PDF)

Keys to the success of the CARMAT project?

M.S. Médecine sciences, 2014-02, Vol.30 (2), p.204

Ménard, Joël

2014

Volltextzugriff (PDF)

Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption

Journal of the American Society of Nephrology, 2004-12, Vol.15 (12), p.3126-3133

2004

Volltextzugriff (PDF)

About fundamentals and sermonizers. Author's response to the letter on the article "The BIAL/Biotrial case of death of a human volunteer in the first-in-human study of BIA 10-2474: Are we missing the fundamentals?"

La Presse médicale (1983), 2017-03, Vol.46 (3), p.352-353

2017

Volltextzugriff (PDF)

Unemployment is associated with high cardiovascular event rate and increased all-cause mortality in middle-aged socially privileged individuals

International archives of occupational and environmental health, 2015-08, Vol.88 (6), p.707-716

2015

Volltextzugriff (PDF)

A vaccine for hypertension

Journal of hypertension, 2007-01, Vol.25 (1), p.41-46

Ménard, Joël

2007

Volltextzugriff (PDF)

The difficult conception, birth and delivery of a renin inhibitor: controversies around aliskiren

Journal of hypertension, 2007-09, Vol.25 (9), p.1775-1782

2007

Volltextzugriff (PDF)

Activity Assays and Immunoassays for Plasma Renin and Prorenin: Information Provided and Precautions Necessary for Accurate Measurement

Clinical chemistry (Baltimore, Md.), 2009-05, Vol.55 (5), p.867-877

2009

Volltextzugriff (PDF)

Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin–angiotensin blockade for left ventricular mass regression in patients with resistant hypertension

Journal of hypertension, 2014-10, Vol.32 (10), p.2038-2044

2014

Volltextzugriff (PDF)

Renin Inhibitors and Cardiovascular and Renal Protection: An Endless Quest?

Cardiovascular drugs and therapy, 2013-04, Vol.27 (2), p.145-153

2013

Volltextzugriff (PDF)

Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists

Circulation (New York, N.Y.), 2004-06, Vol.109 (21), p.2492-2499

2004

Volltextzugriff (PDF)

Clearance systems in the brain-implications for Alzheimer disease

Nature reviews. Neurology, 2015-08, Vol.11 (8), p.457

2015

Volltextzugriff (PDF)

The 45-year story of the development of an anti-aldosterone more specific than spironolactone

Molecular and cellular endocrinology, 2004-03, Vol.217 (1), p.45-52

Ménard, Joël

2004

Volltextzugriff (PDF)

Measure of plan Azheimer's impact on the university hospitals articles production through SIGAPS data

La Presse médicale (1983), 2016-02, Vol.45 (2), p.e1-10

2016

Volltextzugriff (PDF)

Utilisation des données SIGAPS pour mesurer l’impact du plan Alzheimer sur la production d’articles des CHU

La Presse médicale (1983), 2016-02, Vol.45 (2), p.e1-e10

2016

Volltextzugriff (PDF)

Aldosterone synthase inhibition in humans

Nephrology, dialysis, transplantation, 2013-01, Vol.28 (1), p.36-43

2013

Volltextzugriff (PDF)

The Third French Alzheimer Plan: analysis of the influence of a national public health initiative on scientific research productivity and impact

Alzheimer's research & therapy, 2015-09, Vol.7 (1), p.60-60, Article 60

2015

Volltextzugriff (PDF)

1 – 25 von 426

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(391)
Mit Volltextzugriff
(372)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(274)
Life Sciences & Biomedicine
(261)
Humans
(224)
Male
(167)
Biological And Medical Sciences
(141)
Cardiovascular System & Cardiology
(131)
Medical Sciences
(114)
Peripheral Vascular Disease
(100)
Female
(98)
Adult
(93)
Animals
(83)
Middle Aged
(75)
Renin - Blood
(71)
Rats
(62)
Blood Pressure - Drug Effects
(61)
Hypertension
(54)
Cardiology. Vascular System
(53)
Blood And Lymphatic Vessels
(51)
Hypertension - Drug Therapy
(50)
Pharmacology. Drug Treatments
(50)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Trends in Worldwide Research in Hypertension Over the Period 1999–2018: A Bibliometric Study

Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension

Work environment mediates a large part of social inequalities in the incidence of several common cardiovascular risk factors: Findings from the Gazel cohort

Eplerenone Survival Benefits in Heart Failure Patients Post-Myocardial Infarction Are Independent From its Diuretic and Potassium-Sparing Effects: Insights From an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) Substudy

Phylogenetic analysis of West Nile virus in Quebec, Canada, 2004–2016: Co-circulation of distinct variants harbouring conserved amino acid motifs in North America

Masked hypertension: a systematic review

The urgent need for organisational changes of hypertension management in France

The BIAL/Biotrial case of death of a human volunteer in the first-in-human study of BIA 10-2474: Are we missing the fundamentals?

A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism

Keys to the success of the CARMAT project?

Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption

About fundamentals and sermonizers. Author's response to the letter on the article "The BIAL/Biotrial case of death of a human volunteer in the first-in-human study of BIA 10-2474: Are we missing the fundamentals?"

Unemployment is associated with high cardiovascular event rate and increased all-cause mortality in middle-aged socially privileged individuals

A vaccine for hypertension

The difficult conception, birth and delivery of a renin inhibitor: controversies around aliskiren

Activity Assays and Immunoassays for Plasma Renin and Prorenin: Information Provided and Precautions Necessary for Accurate Measurement

Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin–angiotensin blockade for left ventricular mass regression in patients with resistant hypertension

Renin Inhibitors and Cardiovascular and Renal Protection: An Endless Quest?

Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists

Clearance systems in the brain-implications for Alzheimer disease

The 45-year story of the development of an anti-aldosterone more specific than spironolactone

Measure of plan Azheimer's impact on the university hospitals articles production through SIGAPS data

Utilisation des données SIGAPS pour mesurer l’impact du plan Alzheimer sur la production d’articles des CHU

Aldosterone synthase inhibition in humans

The Third French Alzheimer Plan: analysis of the influence of a national public health initiative on scientific research productivity and impact

Suchergebnisse filtern